In Veritas Medical Diagnostics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVMED research report →
About the company
In Veritas Medical Diagnostics, Inc. operates as a development-stage firm, dedicated to researching and developing medical devices designed for near-patient or point-of-care diagnostic applications. The company's flagship product is a prothrombin monitor, crucial for evaluating blood clotting in patients vulnerable to cardiovascular events and cerebrovascular accidents.
- CEO
- G. T. Cooper
- IPO
- 2004
- Employees
- 7
- HQ
- Inverness, GB
Price Chart
- Market Cap
- $120
- P/E
- -0.54
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- -34.02
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 1.86%
- ROIC
- 3.23%
- Revenue
- $0 · 0.00%
- Net Income
- $-107,800 · 0.00%
- EPS
- $-0.00 · 0.00%
- Op Income
- $-107,800
- FCF YoY
- 0.00%
- 52W High
- $0.30
- 52W Low
- $0.00
- 50D MA
- $0.13
- 200D MA
- $0.10
- Beta
- 7.80
- Avg Volume
- 5
Get TickerSpark's AI analysis on IVMED
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IVMED coverage
Recent articles, reports, and earnings notes.
No research on IVMED yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IVMED report →Similar companies
Peers in the same neighborhood.